世華科技(688093.SH):應用於偏光片的光學薄膜已實現新客户認證並量產銷售
格隆匯11月7日丨世華科技(688093.SH)投資者關係活動記錄表顯示,今年上半年,公司光學產線已順利投產,應用於偏光片的光學薄膜已實現新客户認證並量產銷售,實現進口替代。公司一直在積極優化工藝量產能力,以實現持續、穩定、高品質的產品量產。為提高光學材料的產能和生產效率,公司於2022年底已下單採購新的高速產線,該新產線目前已到廠開始安裝,預計明年可以投入使用。公司目前也在持續推動其他光學類產品的驗證,包括上保、下保、支撐膜、防爆膜等,這些產品的驗證週期相對較長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.